The prevalence of multiple sclerosis in 3 US communities

Preventing Chronic Disease

Volumn 7, Issue 1, 2010, Pages

  Noonan, Curtis W ^a   Williamson, Dhelia M ^h   Henry, Judy P ^b   Indian, Robert ^c   Lynch, Sharon G ^d   Neuberger, John S ^d   Schiffer, Randolph ^e   Trottier, Janine ^f   Wagner, Laurie ^b   Marrie, Ruth Ann ^g  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^c OHIO DEPARTMENT OF HEALTH   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f Lorain County General Health District   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; FEMALE; HUMAN; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; RACE; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; UNITED STATES;

EID: 77949331163     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Dean G. How many people in the world have multiple sclerosis? Neuroepidemiology 1994;13(1-2):1-7.
2. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin 1996; 14(2): 291-308.
3. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46(4): 907-11.
4. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112(Pt 1):133-46.
5. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, et al. Primary progressive multiple sclerosis. Brain 1997;120(Pt 6):1085-96.
6. Baum HM, Rothschild BB. The incidence and prevalence of reported multiple sclerosis. Ann Neurol 1981; 10(5): 420-8.
7. Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 1992; 31(3): 333-6.
8. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002; 58(1): 136-8.
9. Williamson DM, Henry JP. Challenges in addressing community concerns regarding clusters of multiple sclerosis and potential environmental exposures. Neuroepidemiology 2004; 23(5): 211-6.
10. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003; 61(10): 1373-7.
11. Multiple sclerosis among Lorain County, Ohio, residents 1998-2000. Atlanta (GA): Agency for Toxic Substances and Disease Registry; 2005.
12. Multiple sclerosis prevalence: Independence and Sugar Creek, Missouri. Atlanta (GA): Agency for Toxic Substances and Disease Registry; 2004.
13. Multiple sclerosis pilot surveillance: 19 Texas counties. Atlanta (GA): Agency for Toxic Substances and Disease Registry; 2004.
14. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13(3): 227-31.
15. Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 2000; 57(6): 418-21.
16. van der Mei IA, Ponsonby AL, Blizzard L, Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20(3): 168-74.
17. National Weather Service. UV index: annual time series. 2004.
18. Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, et al. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 2003; 22(1): 65-74.
19. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. Healthy People 2010 Stat Notes 2001 (20):1-10.
20. Hernan MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in 2 prospective studies of US women. Neurology 1999; 53(8): 1711-8.
21. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22(2): 117-39.
22. Enstrom JE, Operskalski EA. Multiple sclerosis among Spanish-surnamed Californians. Neurology 1978; 28(5): 434-8.
23. Wallin MT, Page WF, Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004; 55(1): 65-71.
24. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008; 71(2): 129-35.
25. McGuigan C, Dunne C, Crowley J, Hagan R, Rooney G, Lawlor E, et al. Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland. J Neurol 2005; 252(10): 1245-8.
26. Ebers GC, Sadovnick AD. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 1993; 12(1): 1-5.
27. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007; 61(6): 504-13.
28. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61(4): 288-99.
29. Nelson LM, Hamman RF, Thompson DS, Baum HM, Boteler DL, Burks JS, et al. Higher than expected prevalence of multiple sclerosis in northern Colorado: dependence on methodologic issues. Neuroepidemiology 1986; 5(1): 17-28.
30. Turabelidze G, Schootman M, Zhu BP, Malone JL, Horowitz S, Weidinger J, et al. Multiple sclerosis prevalence and possible lead exposure. J Neurol Sci 2008;269(1-2):158-62.